S. Lewis Meyer, PhD, has been named president and CEO of Lipid Sciences (Pleasanton, California). He will continue to serve as a director, a position he has held since July 2002. Meyer was president and CEO of Imatron until its acquisition by GE Medical Systems in December 2001. Lipid Sciences is developing the Viral Pathogen Inactivation platform, aimed at selectively removing lipids from proteins. The company said it believes the delipidation process may provide an effective therapeutic effect on many infectious agents, including the viruses that cause AIDS and hepatitis B and C, as well as reverse cardiovascular and cerebrovascular disease.
Charles McGill has been appointed chief financial officer of Recom Managed Systems (Los Angeles, California). McGill previously worked at Teledyne, Allegheny Teledyne and Teledyne Technologies. Recom Managed Systems describes itself as an emerging life sciences company. In September 2002, Recom completed a technology acquisition for purposes of attempting to develop and then commercialize heart-monitoring devices.
Phillip Carter has been named vice president of sales and marketing for Rubicon Medical (Salt Lake City, Utah). Carter previously served as director of global marketing at Precision Vascular. Rubicon is focused on the production and distribution of minimally invasive endovascular products and techniques.